Published in Cell Biochem Biophys on July 01, 2010
H₂S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol (2012) 2.59
A practical look at the chemistry and biology of hydrogen sulfide. Antioxid Redox Signal (2012) 1.60
Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy? Antioxid Redox Signal (2012) 1.17
Thiol reactive probes and chemosensors. Sensors (Basel) (2012) 1.12
Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal (2012) 1.01
Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia. Am J Physiol Cell Physiol (2012) 0.99
Cystathionine β-synthase and cystathionine γ-lyase double gene transfer ameliorate homocysteine-mediated mesangial inflammation through hydrogen sulfide generation. Am J Physiol Cell Physiol (2010) 0.94
The methionine sulfoxide reduction system: selenium utilization and methionine sulfoxide reductase enzymes and their functions. Antioxid Redox Signal (2013) 0.93
Protective role of methionine sulfoxide reductase A against ischemia/reperfusion injury in mouse kidney and its involvement in the regulation of trans-sulfuration pathway. Antioxid Redox Signal (2012) 0.85
Ablation of MMP9 gene ameliorates paracellular permeability and fibrinogen-amyloid beta complex formation during hyperhomocysteinemia. J Cereb Blood Flow Metab (2014) 0.84
Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. Br J Pharmacol (2014) 0.83
Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine. Curr Pharmacogenomics Person Med (2011) 0.83
Hyperhomocysteinemia associates with small vessel disease more closely than large vessel disease. Int J Med Sci (2013) 0.81
Plasma homocysteine is associated with aortic arterial stiffness but not wave reflection in Chinese hypertensive subjects. PLoS One (2014) 0.80
Functional and molecular insights of hydrogen sulfide signaling and protein sulfhydration. J Mol Biol (2016) 0.80
Hydrogen sulfide deactivates common nitrobenzofurazan-based fluorescent thiol labeling reagents. Anal Chem (2014) 0.79
Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes. Mol Cell Biochem (2015) 0.78
Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis. Oxid Med Cell Longev (2015) 0.77
H-Type Hypertension and C Reactive Protein in Recurrence of Ischemic Stroke. Int J Environ Res Public Health (2016) 0.77
Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise. Ann N Y Acad Sci (2016) 0.77
Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension. Pharmacol Res (2016) 0.77
Remodeling in vein expresses arterial phenotype in hyperhomocysteinemia. Int J Physiol Pathophysiol Pharmacol (2011) 0.76
H2S and homocysteine control a novel feedback regulation of cystathionine beta synthase and cystathionine gamma lyase in cardiomyocytes. Sci Rep (2017) 0.75
Folic acid supplementation attenuates hyperhomocysteinemia-induced preeclampsia-like symptoms in rats. Neural Regen Res (2012) 0.75
The Prevalence of Hypertension Accompanied by High Homocysteine and its Risk Factors in a Rural Population: A Cross-Sectional Study from Northeast China. Int J Environ Res Public Health (2017) 0.75
H2S-releasing nanoemulsions: a new formulation to inhibit tumor cells proliferation and improve tissue repair. Oncotarget (2016) 0.75
Effect of losartan with folic acid on plasma homocysteine and vascular ultrastructural changes in spontaneously hypertensive rats. Int J Clin Exp Pathol (2015) 0.75
The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 27.07
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J (2001) 7.97
H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science (2008) 7.89
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ (2002) 7.14
Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J (2002) 6.89
The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci (1996) 6.04
Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med (1997) 5.35
Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol (1969) 5.01
The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun (1997) 4.93
3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal (2009) 3.44
Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem (2009) 3.25
Pathogenesis of hypertension. Ann Intern Med (2003) 3.18
Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol (2004) 2.62
Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med (1985) 2.49
Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J Biol Chem (2009) 2.49
Homocysteine and vascular disease. Nat Med (1996) 2.44
Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA (1995) 2.31
Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest (1996) 2.30
Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest (1986) 2.09
Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem (1997) 1.77
Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet (1998) 1.69
Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation (2001) 1.69
Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol (2005) 1.68
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A (1994) 1.66
Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1. J Biol Chem (2004) 1.56
Hydrogen sulfide induces calcium waves in astrocytes. FASEB J (2004) 1.43
Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am J Physiol Renal Physiol (2009) 1.43
Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol (2008) 1.33
Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest (1996) 1.33
Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int (1999) 1.31
Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J Pathol (2001) 1.30
Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr (2001) 1.30
Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension (1997) 1.26
Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids (2007) 1.23
H2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes. Am J Physiol Cell Physiol (2007) 1.22
Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. Am J Physiol Cell Physiol (2005) 1.22
Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J (1999) 1.21
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol (1999) 1.20
Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Int J Cardiol (2001) 1.17
Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone. Mol Cell Biochem (1998) 1.11
High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation (1997) 1.10
Hyperhomocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations. Circulation (1995) 1.10
Elevated plasma total homocysteine in severe methionine adenosyltransferase I/III deficiency. Metabolism (2002) 1.08
The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol (2008) 1.08
The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels (2004) 1.07
Hyperhomocyst(e)inemia induces multiorgan damage. Heart Vessels (2000) 1.04
Hydrogen sulfide potentiates interleukin-1beta-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells. Biochem Biophys Res Commun (2006) 1.04
The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J Hypertens (2007) 1.02
Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis (1995) 1.01
Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost (2000) 0.99
Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals. Antioxid Redox Signal (2007) 0.99
Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. Am J Physiol (1998) 0.98
Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway. J Cell Physiol (2009) 0.97
Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix. Clin Exp Hypertens (1999) 0.97
The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. Hepatology (2008) 0.96
Elevated expression of liver gamma-cystathionase is required for the maintenance of lactation in rats. J Nutr (1999) 0.95
Stimulation of endothelial nitric oxide production by homocyst(e)ine. Atherosclerosis (1997) 0.94
Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. Am J Reprod Immunol (2001) 0.93
Homocysteine and essential hypertension. J Clin Pharmacol (2003) 0.93
Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol (1997) 0.91
Effects of hydrogen sulfide on hypoxic pulmonary vascular structural remodeling. Life Sci (2005) 0.91
Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms. J Lipid Res (1993) 0.91
Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells. J Cell Physiol (2000) 0.91
Mild hyperhomocysteinaemia is associated with increased aortic stiffness in general population. J Hum Hypertens (2006) 0.91
Homocyst(e)ine impairs endocardial endothelial function. Can J Physiol Pharmacol (1999) 0.90
Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine. Atherosclerosis (1996) 0.89
Increased plasma copper in patients with homocystinuria due to cystathionine beta-synthase deficiency. Clin Chim Acta (1983) 0.89
Calcium overload--an important cellular mechanism in hypertension and arteriosclerosis. Drugs (1992) 0.87
Homocysteine induces synthesis of a serine elastase in arterial smooth muscle cells from multi-organ donors. Cardiovasc Res (1997) 0.87
Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling. Clin Chem Lab Med (2007) 0.87
Homocysteine induces connective tissue growth factor expression in vascular smooth muscle cells. J Thromb Haemost (2007) 0.87
A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage. Am J Hypertens (2001) 0.86
Effect of calcium channel blockers on proteoglycan synthesis by vascular smooth muscle cells and low density lipoprotein--proteoglycan interaction. Atherosclerosis (2001) 0.84
Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease. Semin Thromb Hemost (2000) 0.84
Myosin isoform shifts and decreased reactivity in hypoxia-induced hypertensive pulmonary arterial muscle. Am J Physiol (1998) 0.84
Vascular smooth muscle cell migration, atherosclerosis, and calcium channel blockers. Int J Cardiol (1997) 0.84
Dietary lipid modulation of connective tissue matrix in rat abdominal aorta. Am J Physiol (1992) 0.83
Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension. Hypertension (1997) 0.82
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. Eur J Pharmacol (2008) 0.81
Patients with homocystinuria: high metal concentrations in hair, blood and urine. Acta Neurol Scand (1992) 0.80
Effects of several unusual sulfur-containing amino acids on rat liver cystathionine-gamma-lyase. Physiol Chem Phys (1975) 0.78
Hypercontractility of vascular muscle in atherosclerosis. Circulation (1997) 0.78
Effect of sodium deprivation on cardiac hypertrophy in spontaneously hypertensive rats: influence of aging. J Mol Cell Cardiol (1991) 0.78
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) (2004) 2.13
Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am J Physiol Lung Cell Mol Physiol (2002) 1.76
Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats. J Hypertens (2003) 1.71
Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol (2005) 1.68
MicroRNAs as a therapeutic target for cardiovascular diseases. J Cell Mol Med (2009) 1.67
Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol (2005) 1.59
Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: an implication to coronary vasospasm. J Cell Physiol (2011) 1.54
Pioglitazone prevents cardiac remodeling in high-fat, high-calorie-induced Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol (2006) 1.50
Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy. Cardiovasc Diabetol (2002) 1.46
Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am J Physiol Renal Physiol (2009) 1.43
Folic acid improves inner ear vascularization in hyperhomocysteinemic mice. Hear Res (2011) 1.42
Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart Circ Physiol (2005) 1.35
Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J Exp Med (2007) 1.32
Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol (2013) 1.32
H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid Redox Signal (2009) 1.30
Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure. PLoS One (2012) 1.28
Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis. Int J Biol Sci (2012) 1.27
Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. J Biol Chem (2004) 1.24
H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure. Am J Physiol Heart Circ Physiol (2009) 1.23
Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. Am J Physiol Cell Physiol (2005) 1.22
Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells. Am J Physiol Cell Physiol (2007) 1.22
Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure. J Appl Physiol (1985) (2011) 1.18
Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. Am J Physiol Heart Circ Physiol (2008) 1.17
Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. Antioxid Redox Signal (2011) 1.16
Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. Am J Nephrol (2010) 1.16
Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice. J Appl Physiol (1985) (2005) 1.14
Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. J Cell Biochem (2006) 1.14
The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded. Cardiovasc Diabetol (2005) 1.14
Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats. Am J Physiol Heart Circ Physiol (2002) 1.14
Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Heart Circ Physiol (2006) 1.13
MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure. Arch Physiol Biochem (2010) 1.12
MicroRNAs are involved in homocysteine-induced cardiac remodeling. Cell Biochem Biophys (2009) 1.11
Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery. Neurochem Int (2008) 1.11
Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation. Cardiovasc Diabetol (2004) 1.11
Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus. Am J Physiol Renal Physiol (2006) 1.10
Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens (2002) 1.10
Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr J (2004) 1.07
Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR. Am J Physiol Cell Physiol (2002) 1.06
Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure. Am J Physiol Heart Circ Physiol (2005) 1.06
Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure. J Cell Mol Med (2005) 1.06
Type 2 diabetes mellitus as a conformational disease. JOP (2005) 1.06
Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes (2013) 1.05
Hydrogen sulfide protects against vascular remodeling from endothelial damage. Amino Acids (2010) 1.05
Fibrinogen induces endothelial cell permeability. Mol Cell Biochem (2007) 1.05
MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA. Cell Biochem Biophys (2010) 1.04
Attenuation of oxidative stress and remodeling by cardiac inhibitor of metalloproteinase protein transfer. Circulation (2004) 1.04
Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid. J Mol Neurosci (2014) 1.03
Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia. J Cell Physiol (2008) 1.02
Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice. Am J Physiol Lung Cell Mol Physiol (2010) 1.01
GABA receptors ameliorate Hcy-mediated integrin shedding and constrictive collagen remodeling in microvascular endothelial cells. Cell Biochem Biophys (2006) 1.00
Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance. Am J Physiol Endocrinol Metab (2008) 1.00
gamma-Aminbuturic acid A receptor mitigates homocysteine-induced endothelial cell permeability. Endothelium (2007) 1.00
Cardioprotective role of sodium thiosulfate on chronic heart failure by modulating endogenous H2S generation. Pharmacology (2008) 1.00
Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke. Mol Neurobiol (2013) 1.00
Defective homocysteine metabolism: potential implications for skeletal muscle malfunction. Int J Mol Sci (2013) 0.99
Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia. Am J Physiol Cell Physiol (2012) 0.99
Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia. J Cell Biochem (2005) 0.99
Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide. J Cell Biochem (2005) 0.99
Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts. Cell Biochem Biophys (2014) 0.98
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol. Cardiovasc Diabetol (2010) 0.98
Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling. Pflugers Arch (2014) 0.98
Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice. J Cell Biochem (2009) 0.98
Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone. Int J Biol Sci (2007) 0.98